Your browser doesn't support javascript.
loading
Progress of prokineticin 2 in cardiovascular diseases / 中国药理学通报
Chinese Pharmacological Bulletin ; (12): 892-894, 2018.
Article in Zh | WPRIM | ID: wpr-705147
Responsible library: WPRO
ABSTRACT
Cardiovascular diseases are characterized by cardiac and vascular dysfunction. Prokineticin 2 ( PK2 ) is a newly found secretory peptide which plays a key role in the physiology homeostasis via prokineticin receptor 1 and 2 ( PKR1 and 2). Furthermore, PK2/PKR1 signaling pathway plays an important role in protecting cardiovascular diseases. Here we discuss the effect of PK2/PKR1 signaling in myocardial infarction, conges-tive heart failure and vascular endothelial dysfunction.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Pharmacological Bulletin Year: 2018 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Pharmacological Bulletin Year: 2018 Type: Article